Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

Corresponding Author: Jason K. Russell, PhD, Alzheimer’s Therapeutic Research Institute, Keck School of Medicine, University of Southern California, 9860 Mesa Rim Rd, San Diego, CA 92121 (jasonkru@usc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.